Trials / Recruiting
RecruitingNCT06362304
99mTc-CNDG SPECT/CT in Brain Tumors
Application of 99mTc-CNDG SPECT/CT Imaging in the Diagnosis of Brain Tumors
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to evaluate the value of 99mTc-CNDG for diagnosis of brain tumors by comparing it with 18F-FDG-PET. The main questions it aims to answer are: 1. What is the diagnostic consistency between 99mTc-CNDG and 18F-FDG? 2. What is the correlation between the SUVmax value of 99mTc-CNDG and tumor type? Participants will: Receive18F-FDG-PET and 99mTc-CNDG examination within 2 weeks before surgery. Obtain pathological diagnosis by surgery or biopsy as the gold standard.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | 99mTc-CNDG SPECT/CT | FDG-PET and 99mTc-CNDG will be performed within 2 weeks before surgery. |
Timeline
- Start date
- 2024-04-20
- Primary completion
- 2025-02-01
- Completion
- 2025-04-01
- First posted
- 2024-04-12
- Last updated
- 2024-11-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06362304. Inclusion in this directory is not an endorsement.